Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $17.36, but opened at $16.72. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $16.78, with a volume of 3,158 shares.
Wall Street Analyst Weigh In
Several equities analysts have issued reports on TLX shares. Wedbush initiated coverage on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Thursday. They issued an "outperform" rating and a $22.00 price target on the stock. William Blair reiterated an "outperform" rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Wednesday, March 12th.
View Our Latest Report on TLX
Telix Pharmaceuticals Limited American Depositary Shares Trading Down 3.4%
The company's 50 day moving average price is $16.76 and its 200 day moving average price is $16.83.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Telix Pharmaceuticals Limited American Depositary Shares stock. Private Advisor Group LLC bought a new stake in shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 10,140 shares of the company's stock, valued at approximately $170,000.
Telix Pharmaceuticals Limited American Depositary Shares Company Profile
(
Get Free Report)
Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.
See Also
Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.
While Telix Pharmaceuticals Limited American Depositary Shares currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
